http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101313027-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C327-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C327-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate | 2005-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101313027-B1 |
| titleOfInvention | Bis (thio-hydrazide amide) salt for cancer treatment |
| abstract | The present invention relates to a bis (thio-hydrazide amide) dichloride represented by the following formula (I), wherein Y is a covalent bond or a substituted or unsubstituted straight chain hydrocarbyl group. R 1 to R 4 are independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group, or R 1 and R 3 together with the carbon and nitrogen atoms bonded thereto, and / or R 2 and R 4 together with the carbon and nitrogen atoms bonded thereto form a non-aromatic heterocyclic ring fused or unfused to the aromatic ring. Z is -O or -S. M + is a pharmaceutically acceptable monovalent cation and M 2+ is a pharmaceutically acceptable divalent cation. The present invention also relates to pharmaceutical compositions comprising the bis (thio-hydrazide amide) di salts described above. The present invention also relates to a method of treating a subject with cancer. This method comprises administering an effective amount of the bis (thio-hydrazide amide) di salt described above. |
| priorityDate | 2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 760.